51 / 400
SPECIAL SESSIONS
43
Jean Delay Prize
Jules Angst is awarded the WPA Jean Delay Prize
2017. The Jean Delay Prize is the most prestigious
award that WPA gives triennially. It is awarded to
an individual who has made a major contribution
in the biological, psychological or social aspects
of psychiatry or has built useful bridges between
them.
Jules Angst, Department of Psychiatry, Psychotherapy
and Psychosomatics, University of Zurich, Switzerland is
awarded the WPA Jean Delay Prize 2017. At its meeting,
the International Jury unanimously decided to award the
Prize to him. This consists of a certificate and a cheque
for EUR 40,000 paid for by SERVIER. The Prize will be
presented by WPA President Dinesh Bhugra at the open-
ing ceremony of the World Congress of Psychiatry, Ber-
lin on Oct 8, 2017. Hearty congratulations to Jules Angst
on this achievement.
Bio sketch
Jules Angst, MD, is Emeritus
Professor of Psychiatry at the
University of Zurich, Switzer-
land and Honorary Doctor of
the Universities of Heidelberg,
Germany, and Craiova, Romania.
In his early twenties Jules Angst
qualified as a Jungian analyst.
He trained in psychiatry under Manfred Bleuler at the
Zurich University Psychiatric Hospital (the Burghölzli),
where he went on to head the Research Department
from 1969 until his retirement in 1994. His publica-
tions span the past 60 years of clinical psychiatry. He
remains active in epidemiological and clinical research.
Jules Angst's monograph (1966) established and validat-
ed the distinction between bipolar disorder, depression,
and schizoaffective disorders on the basis of genetics,
course, and personality. Later patient studies led to the
development of a new mood spectrum concept of three
dimensions: syndrome (mania to depression), severity
(normal to psychotic) and temperament. He proposed
improved diagnostic concepts of bipolar-I and bipolar-II
disorders. His early work in clinical psychopharmacolo-
gy established the efficacy of and the familial response
to imipramine (1964). On the basis of multicentre stud-
ies he provided statistical evidence for the long-term ef-
ficacy of lithium (1970). His more recent work focused
on the long-term prophylactic role of antidepressants
and atypical neuroleptics in suicide prevention, the early
onset of action of antidepressants, "drug-induced” hy-
pomania, and the effect of lithium against dementia in
patients with mood disorders.
Award Ceremony: 8 Oct 2017
17:30– 19:15
|
Hall B
Laudation:
Dinesh Bhugra, United Kingdom
Session: Opening Ceremony
Prize money: EUR 40,000
›
supported by SERVIER